These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


341 related items for PubMed ID: 15049961

  • 21. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, Jørgensen JO, Sonksen PH, GH-2000 Study Group.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [Abstract] [Full Text] [Related]

  • 22. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L, Mancini A, Izzi D, Bianchi A, Giampietro A, Fusco A, Liberale I, Rossi S, Valle D.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [Abstract] [Full Text] [Related]

  • 23. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 24. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Macut D, Vukojevic P, Joksimovic MM.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [Abstract] [Full Text] [Related]

  • 25. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
    Rasmussen MH, Juul A, Hilsted J.
    Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
    [Abstract] [Full Text] [Related]

  • 26. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C, Cappiello V, Corbetta S, Ronchi CL, Morpurgo PS, Ferrante E, Beck-Peccoz P, Spada A.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [Abstract] [Full Text] [Related]

  • 27. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J, van der Lelij AJ, Feelders RA, de Herder WW, Uitterlinden P, Poon KW, Boerlin V, Lewis I, Krahnke T, Hofland LJ, Lamberts SW.
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [Abstract] [Full Text] [Related]

  • 28. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 29. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
    Ehrnborg C, Ohlsson C, Mohan S, Bengtsson BA, Rosén T.
    Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
    [Abstract] [Full Text] [Related]

  • 30. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA).
    Tsatsoulis A, Siamopoulou A, Petsoukis C, Challa A, Bairaktari E, Seferiadis K.
    Growth Horm IGF Res; 1999 Apr; 9(2):143-9. PubMed ID: 10373347
    [Abstract] [Full Text] [Related]

  • 31. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 32. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [Abstract] [Full Text] [Related]

  • 33. Effect of growth hormone administration to mature miniature Brahman cattle treated with or without insulin on circulating concentrations of insulin-like growth factor-I and other metabolic hormones and metabolites.
    Chase CC, Elsasser TH, Spicer LJ, Riley DG, Lucy MC, Hammond AC, Olson TA, Coleman SW.
    Domest Anim Endocrinol; 2011 Jul; 41(1):1-13. PubMed ID: 21420268
    [Abstract] [Full Text] [Related]

  • 34. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
    Amin R, Williams RM, Frystyk J, Umpleby M, Matthews D, Orskov H, Dalton RN, Dunger DB.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188
    [Abstract] [Full Text] [Related]

  • 35. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 36. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ, Grande C, Méndez J, González-Gancedo P, Iglesias P.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
    [Abstract] [Full Text] [Related]

  • 38. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
    Minuto F, Resmini E, Boschetti M, Arvigo M, Sormani MP, Giusti M, Ferone D, Barreca A.
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
    [Abstract] [Full Text] [Related]

  • 39. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E.
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [Abstract] [Full Text] [Related]

  • 40. Increased adrenal androgen secretion with inhibition of 11beta-hydroxylase in HIV-infected women.
    Koutkia P, Berry J, Eaton K, Breu J, Grinspoon S.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E808-13. PubMed ID: 16303845
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.